Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Exacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapy
Respiratory Medicine, 09/15/09
Campos MA et al. – COPD exacerbations occur frequently and are associated with significant disease burden in subjects with AATD receiving augmentation therapy.
Related Articles
Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?
Expert Opinion in Pharmacotherapy, 11/06/09
Relevance Score: 80%
The liver in 30-year-old individuals with alpha 1 -antitrypsin deficiency
Scandinavian Journal of Gastroenterology, 11/06/09
Relevance Score: 79%
Anti-apoptotic effects of Z alpha-1 antitrypsin in human bronchial epithelial cells
European Respiratory Journal, 10/20/09
Relevance Score: 66%
Z and Mmalton-1-antitrypsin deficiency-associated hepatocellular carcinoma: a genetic study
Liver International, 10/08/09
Relevance Score: 65%
Recognition and Management of Vitamin D Deficiency
American Family Physician, 10/19/09
Relevance Score: 46%
Today in COPD...keeping you current
Receive free subspecialty "5-minute updates" via email
Epidemiology of COPD
European Respiratory Review, 12/08/09
Smoking-related Lung Disease
Journal of Thoracic Imaging, 12/07/09
Pulmonary Rehabilitation and Pharmacotherapy
Seminars in Respiratory and Critical Care Medicine, 12/07/09
Sponsor
Article Search
Sponsor


See Latest Articles


